公司资料
Vanda Pharmaceuticals 股价、新闻与催化剂
- 股票代码:
- VNDA
- 交易所:
- NASDAQ
- 行业:
- Biopharma
- 所在地:
- United States
股票表现
5.28 USD (-1.86%)
收盘价
最后更新: 2026年8月21日
369M USD
市值
股价为何变动
As of Aug 21, 2026, VNDA closed down 1.86% at $5.28. No new same-company headline was identified in the current news window.
公司概览
业务概览
Vanda Pharmaceuticals is a specialty pharma company with an emphasis on neuroscience and sleep-related therapies. Its business has long centered on commercial products and selective pipeline development.
所在地与行业分类
Headquartered in the United States and listed on NASDAQ, Vanda sits in specialty biopharma.
商业模式特征
The company depends on product revenue, label positioning, and the ability to build new assets around a concentrated commercial base.
生物医药行业定位
Vanda is a commercial specialty-pharma name whose valuation is tied to product durability and pipeline optionality.
未来催化剂
- Vanda’s catalysts are HETLIOZ and Fanapt execution, plus any regulatory or litigation update tied to the sleep franchise. The stock usually moves when the company shows that the commercial base can stay durable.
近期新闻
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。